All In Nutritionals
Facebook Instagram Linkedin Twitter Website
Home Blog Page 278

At Some Gyms, “Pumped” is taking on a Whole New Meaning  

By
Editor
-
0
At Some Gyms

Health and bodybuilding supplements come in all sorts of interesting formulations, but according to Nick Eagland, a reporter for The Province, the worlds oldest and most natural formulation seems to be undergoing a resurgence.

 

In an article that has been reprinted across Canada and is trending on Social Media, the reporter presents an astonishing (and some say gut-churning) update on what he claims is a new fad among the body-building intelligensia.

 

Citing the case of Jennifer Rowse, a Langley based nutritionist who has sold her breast milk on Craigslist, Eagland tracks down an array of bodybuilders, milk-donors, medical health officers and even the odd retailer whose comments range from “I heard of it but never thought it was true!” to “It’s a urban myth,” to opinions about its safety and nutritional value.

 

Apparently, buyers search for it on “milk-sharing” sites like Only the Breast and on classified sites like Craigslist. And prices range from about two dollars to 20 dollars an ounce for freshly pumped breast milk.

 

Even if it sounds to you like a viable source of carbs, fat and protein, there are definitely dangers in buying it from unregulated sources, because frankly you don’t know what you’re getting – and it could contain anything from parasites to HIV or Hep C. And if you approach someone privately to buy it, there’s definitely a danger of coming off more than a little bit kinky. Even the most upright and prim of breast milk “producers” has had to turn down offers from people actually interested in the act of breastfeeding.

 

But from a pure health food stand-point, one can’t help but wonder if this truly qualified as a performance enhancing supplement.

 

By the way, the sale and distribution of human milk for consumption is regulated under the Food and Drugs Act and Regulations, which is enforced by the Canadian Food Inspection Agency.

 

A Vancouver Police Department spokesperson stated that there’s “no criminal offence for selling” breast milk online.

 

Read more on this topic:

http://nymag.com/thecut/2014/05/meet-the-men-who-drink-breast-milk.html

http://www.theprovince.com/sure+want+drink+that+Breast+milk+mixed+muscle+building/10834072/story.html

Omega-3 DHA and EPA named 2015 Ingredients to Watch

By
Editor
-
0
Omega-3 DHA and EPA named 2015 Ingredients to Watch

After a significant drop in sales in the US over the past year and a half, 2015 should bring some positive news for omega-3 fatty acids EPA and DHA, according to the Global Organization for EPA and DHA (GOED).

 

“For 2015, GOED anticipates a flurry of domestic as well as international industry-shaping regulatory activity associated with EPA and DHA,” says Harry Rice, PhD, GOED’s vice president of regulatory and scientific affairs and a Nutritional Outlook editorial advisory board member. Rice points to key regulatory developments that will, if they pan out, reinforce to consumers the importance of EPA and DHA intake.

 

On the international front, the Codex Alimentarius Commission, part of the FAO/WHO that develops international food standards, continues its work to devise a final draft for the first-ever Codex Alimentarius standard for fish oils. Although Codex does not have regulatory power, some countries do adopt Codex standards as their own. The goal now is fine-tuning and reaching a final draft, which the Codex Committee for Fats and Oils has been working to achieve for years. At its 24th session this February, the committee was scheduled to continue discussions on the proposed draft of the standard, including addressing new comments and revisions suggested by omega-3 stakeholders. At its Malaysia meeting earlier this month, Codex decided to include krill, salmon, and menhaden oils in the draft standard.

 

Meanwhile, last November, the Codex Committee on Nutrition and Foods for Special Dietary Uses approved a proposal to eventually establish a Nutrient Reference Value (NRV) for EPA and DHA omega-3s. A NRV would represent a global recommended intake for these fatty acids, much like a dietary reference intake (DRI) value in the United States. It would, says GOED, underline the importance of EPA and DHA intake to the entire global community.

 

In the US and Canada, EPA and DHA are being considered for a DRI of their very own. Before deciding on which nutrients will next undergo official DRI review—there are several in contention, in addition to EPA and DHA—a U.S. and Canadian nutrient assessment group is meeting this March to first discuss the use of chronic disease endpoints when setting DRI nutrient values. Because current science on many of the nutrients nominated for DRI reviews includes links to chronic disease, the committees believe they must first decide on how to approach these disease endpoints.

 

This May should also bring final word on GOED’s long-awaited FDA petition for a health claim linking EPA and DHA with the reduction of blood pressure in the general population. After reviewing the science submitted, FDA decided it will now approach this health claim as a qualified health claim. (As opposed to an authorized health claim, a qualified claim must be accompanied by a disclaimer communicating to consumers the level of scientific evidence supporting the claim.)

 

Hain Celestial Announces Accretive Strategic Acquisition

By
Editor
-
0
Hain Celestial Announces Accretive Strategic Acquisition

Acquires Live Clean® Personal Care Brand in Canada

Expands Health and Beauty Care Offerings with Diversified Line of Baby, Body and Hair Care Products

The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life™, today announced the acquisition of Belvedere International, Inc., (“Belvedere”) a leader in health and beauty care products including the Live Clean® brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.

“We are excited by the acquisition of the Live Clean brand, which expands our presence in the personal care category and complements our Avalon Organics®, Alba Botanica® and JASON® brands that we sell into Canada.  This acquisition increases the scale of our Canadian operations to over $150 million in net sales and provides us with opportunities for sales expansion and cost efficiencies as we leverage our existing infrastructure in Canada and our manufacturing and research and development expertise in personal care,” said Irwin D. Simon, Founder, President and Chief Executive Officer of Hain Celestial.

“It is with great pride that I see my family’s business become part of the esteemed Hain Celestial Group. I believe under their stewardship the Live Clean brand will reach great heights,” said Sandra Belvedere.

The Live Clean brand is the leading natural hair care and baby care brand in Canada. In calendar year 2014 Belvedere had approximately $25 million in net sales and is expected to be accretive to Hain Celestial’s earnings in fiscal year 2016.  Belvedere, which was founded by Rocco Donald Belvedere in 1981, was a family-owned company led by Larry Romagnuolo, President and Chief Executive Officer.

“The Live Clean brand establishes a personal care base of operations in Canada for Hain Celestial, which can serve as the foundation for the continued growth of all our personal care brands and provide us with an opportunity to expand the brand beyond the Canadian mass channel,” commented Beena Goldenberg, President of Hain Celestial Canada.

“I am pleased the employees of Belvedere are joining Hain Celestial Canada, who can ensure the next level of growth for the personal care business established by my family 34 years ago, and I look forward to working with Beena Goldenberg and the Hain Celestial team in pursuing new opportunities as part of a leading organic and natural products company,” said Larry Romagnuolo, who is himself joining Hain Celestial Canada as General Manager, Personal Care where he will be responsible for the Live Clean brand as well as Avalon Organics®, Alba Botanica® and JASON brands in Canada.

Coffee Fruit Extract May Provide Cognitive Health Benefits

By
Editor
-
0

KonaRed Corporation, manufacturers of Antioxidant Juices and nutritional supplements from the exclusive and highly effective Hawaiian CoffeeBerry®, coffee fruit from Kona, Hawaii, announced that its partner FutureCeuticals, was featured in the article, “Cognitive health appeals to all demographics”, published in the February 16, 2015 edition of Beverage Industry. The article cites that the coffee fruit extract that is used in KonaRed’s beverages and supplement powders has been reported to increase serum levels of certain proteins linked to mood and memory, and may provide cognitive health benefits that appeal to all demographics.

 

An excerpt from the article states:

“In the case of CoffeeBerry® coffee fruit extract, we discovered that it has a unique capacity to increase serum levels of brain-derived neurotropic factor (BDNF), which is a key neuro-protein involved in cognition, mood and other key neuro-processes. We chose to focus on cognition and mood, given the enormous public interest in cognitive and mental health at all age levels. Baby boomers frequently cite cognitive health as their No. 1 concern, and younger people are motivated to take action now to help ensure a higher quality of life as they age.”

 

KonaRed’s CEO Shaun Roberts stated, “In addition to supporting healthy cognition, clarity, mood, focus that are crucial to everyone regardless of age, CoffeeBerry® coffee fruit also delivers beneficial antioxidative qualities and phytonutrients that may promote other wellness qualities such as increased energy and healthy immune response. This superfruit forms a key component of our functional beverages and wellness products and provides exciting value to the consumer.”

British Columbia and Ontario Pharmacists to Provide New Cardiovascular Program to Patients

By
Editor
-
0

Green Shield Canada, in partnership with the Ontario Pharmacists Association and the British Columbia Pharmacy Association, launched a pharmacist counselling service focused on cardiovascular health. The Pharmacist Health Coaching program is designed to improve the health outcomes of patients with hypertension and high cholesterol, and reduce health benefits costs. It is now available to plan members of Green Shield Canada’s health benefits plans in Ontario and British Columbia. Green Shield Canada will be actively engaging additional provinces in the program as the year progresses.

 

Under the program, pharmacists offer eligible patients support and counselling on managing high blood pressure and high cholesterol through one-on-one sessions. The program’s objective is to empower participants to take responsibility for their overall health – it will focus on diet, exercise, smoking cessation, drug therapy adherence and personal health monitoring. Training has been developed for pharmacists delivering the program, and remuneration will be made available for the counselling services provided.

 

The Pharmacist Health Coaching program is based on a study sponsored by Green Shield Canada, in partnership with the Ontario Pharmacists Association and other organizations (including the Heart and Stroke Foundation) that tested the effectiveness of pharmacists’ hypertension management services. Patients with uncontrolled hypertension met regularly with their pharmacists, who provided medication and lifestyle counselling and monitored blood pressure. The results of the study provided clear evidence that a significant percentage of patients who received a pharmacist’s support had lower blood pressure, lower body mass index, improved medication compliance and reduced drug costs compared to a control group of patients who did not receive pharmacist support.

 

“Our experience shows that a key element of managing overall health benefits costs for our clients is helping their employees better manage their personal health. And pharmacists have a natural point of interaction with them,” said Steve Bradie, president and CEO of Green Shield Canada. “Through this investment in health management, our goal is to not only improve health outcomes and influence drug therapy adherence, but also lower overall plan costs and, in the end, deliver savings to the Canadian health care system.”

 

“We are very pleased to be able to provide this service to patients in British Columbia,” said Geraldine Vance, CEO of the British Columbia Pharmacy Association. “Pharmacists are easily accessible to most British Columbians and can meet frequently with patients. That means better adherence to medications and healthy behaviours.”

 

“We are excited to be able to build on the success of the pilot program and to offer this important pharmacy service to all eligible patients in this province,” said Dennis Darby, CEO of the Ontario Pharmacists Association. “As medication experts and trusted health care providers, pharmacists are ideally placed to help raise awareness of the risk factors leading to heart disease and stroke, to play a key role in early detection, and to help patients manage their various medication therapies.”

 

“High blood pressure and high cholesterol are primary risk factors for cardiovascular disease – we applaud the pharmacy associations and Green Shield Canada for implementing a program that will go a long way in helping those living with these risks to control their blood pressure and cholesterol levels, make lifestyle changes and improve their medication regimens,” said Dr. Gavin Arthur, director, Promote Recovery, Heart and Stroke Foundation.

 

About Green Shield Canada
Green Shield Canada (GSC) is a benefits specialist. It’s what they do. But as Canada’s only national not-for-profit health and dental specialist, their reason for being is the enhancement of the common good. GSC seeks out innovative ways to improve access to better health for Canadians. From coast-to-coast, their service delivery includes drug, dental, extended health care, vision, hospital and travel benefits for groups and individuals, as well as administration services. Supported by cost containment strategies, advanced technology and exceptional customer service, they create customized programs for over one and a half million plan participants nationwide.

PROVENGE® (sipuleucel-T) Demonstrates Sustained Immune Response Two Years after Treatment in Biochemically-Recurrent Prostate Cancer

By
Editor
-
0

Valeant Pharmaceuticals International, Inc. announced the presentation of new long-term, preliminary results from the Phase II STAND trial demonstrating a robust immune response with PROVENGE® (sipuleucel-T) that continues two years after completing treatment in men with biochemically-recurrent prostate cancer (BRPC). The findings, along with valuable data from the ongoing Phase IV registry, PROCEED, related to increasing enrollment of African Americans in prostate cancer trials, are being presented at the 2015 Genitourinary Cancers Symposium (ASCO GU) February 26-28 in Orlando, Florida.

 

The STAND study is a randomized, Phase II trial that consisted of two patient study groups. One group completed PROVENGE two weeks before initiation of androgen deprivation therapy (ADT) and the second received PROVENGE three months after the start of ADT. PROVENGE is not indicated for use in patients with BRPC. Preliminary results from STAND indicate that immune responses were observed in both study arms and suggest there may be a greater cellular immune response in patients who received PROVENGE prior to ADT compared with those who received PROVENGE following three months of ADT. Humoral immune responses were observed and similar between both treatment arms.

 

“It is very encouraging to observe that PROVENGE provides an immune response in men with biochemical-recurrent prostate cancer long after the course of androgen deprivation therapy has ended,” said Neal Shore, M.D., medical director at the Carolina Urologic Research Center. “This study may also provide guidance on the optimal sequencing of immunotherapy and ADT in biochemical-recurrent prostate cancer.”

 

PROVENGE, the first personalized immunotherapy, stimulates a patient’s own immune system to fight cancer. It is approved in the U.S. and the European Union as a treatment for asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer.

 

“These are very encouraging preliminary data and the longest duration of immune responses observed following PROVENGE completion in men with this particular type of prostate cancer,” said Andrew S. Sandler, M.D., chief medical officer at Dendreon. “Dendreon and Valeant remains committed to exploring the use of PROVENGE in different prostate cancer treatment settings to provide important clinical information to practicing oncologists.”

 

In 2012, an exploratory analysis of African American patients from the PROVENGE Phase III trials suggested a positive treatment effect in this population. Building on this observation, another abstract being presented at ASCO GU highlights successful efforts that nearly doubled enrollment of African American men in the ongoing PROCEED registry. Through tactics such as utilizing research sites in racially and ethnically diverse communities, conducting focus groups with African Americans for insight on recruitment materials and study plans, and educating research staff on enrollment goals, enrollment in this population was 11.7 percent, a rate comparable to the U.S. African American population, versus 5.8 percent in the PROVENGE Phase III registration trials. Overall, African American men are underrepresented in randomized clinical trials for prostate cancer, yet they have the highest incidence rate for prostate cancer in the United States and are more than twice as likely as white men to die of the disease.i

 

Important Safety Information for PROVENGE

PROVENGE® (sipuleucel-T) is an autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone-refractory) prostate cancer.

Before getting PROVENGE, tell your doctor if you:

  • Have heart problems
  • Have lung problems
  • Have a history of stroke
  • Take any other medicines including prescription and nonprescription drugs, vitamins, and dietary supplements.

What are the possible side effects of PROVENGE?

PROVENGE infusion can cause serious reactions.

Tell your doctor right away if you:

  • Have breathing problems, chest pains, racing heart or irregular heartbeats, high or low blood pressure, dizziness, fainting, nausea, or vomiting after getting PROVENGE. Any of these may be signs of heart or lung problems.
  • Develop numbness or weakness on one side of the body, decreased vision in one eye or difficulty speaking. Any of these may be signs of a stroke.
  • Develop symptoms of thrombosis which may include pain and/or swelling of an arm or leg with warmth over the affected area, discoloration of an arm or leg, unexplained shortness of breath or chest pain that worsens on deep breathing.
  • Get a fever over 100°F, or redness or pain at the infusion or collection sites. Any of these may be signs of infection.

The most common side effects of PROVENGE include chills, fatigue, fever, back pain, nausea, joint ache, and headache.

These are not all the possible side effects of PROVENGE treatment. For more information, talk with your doctor.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

For more information on PROVENGE, please see the Full Prescribing Information or call 1-877-336-3736.

About Valeant

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.  On February 23, 2015, Valeant acquired the worldwide rights to PROVENGE, as well as certain other assets, from Dendreon Corporation.

About Dendreon

Dendreon’s first product, PROVENGE® (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers.  For more information about the Company and its programs, visit http://www.dendreon.com/.

 

At Some Gyms, Pumped is Taking on a Whole New Meaning

By
Editor
-
0

breastpumpSMHealth and bodybuilding supplements come in all sorts of interesting formulations, but according to Nick Eagland, a reporter for The Province, the worlds oldest and most natural formulation seems to be undergoing a resurgence.

 

In an article that has been reprinted across Canada and is trending on Social Media, the reporter presents an astonishing (and some say gut-churning) update on what he claims is a new fad among the body-building intelligensia.

 

Citing the case of Jennifer Rowse, a Langley based nutritionist who has sold her breast milk on Craigslist, Eagland tracks down an array of bodybuilders, milk-donors, medical health officers and even the odd retailer whose comments range from “I heard of it but never thought it was true!” to “It’s a urban myth,” to opinions about its safety and nutritional value.

 

Apparently, buyers search for it on “milk-sharing” sites like Only the Breast and on classified sites like Craigslist. And prices range from about two dollars to 20 dollars an ounce for freshly pumped breast milk.

 

Even if it sounds to you like a viable source of carbs, fat and protein, there are definitely dangers in buying it from unregulated sources, because frankly you don’t know what you’re getting – and it could contain anything from parasites to HIV or Hep C. And if you approach someone privately to buy it, there’s definitely a danger of coming off more than a little bit kinky. Even the most upright and prim of breast milk “producers” has had to turn down offers from people actually interested in the act of breastfeeding.

 

But from a pure health food stand-point, one can’t help but wonder if this truly qualified as a performance enhancing supplement.

 

By the way, the sale and distribution of human milk for consumption is regulated under the Food and Drugs Act and Regulations, which is enforced by the Canadian Food Inspection Agency.

 

A Vancouver Police Department spokesperson stated that there’s “no criminal offence for selling” breast milk online.

 

Read more on this topic:

http://nymag.com/thecut/2014/05/meet-the-men-who-drink-breast-milk.html

http://www.theprovince.com/sure+want+drink+that+Breast+milk+mixed+muscle+building/10834072/story.html

Therapeutic Potential of Stem Cells from Fatty Tissue for Treating Diabetic Skin Ulcers

By
Editor
-
0

Human adipose-derived stem cells (hASCs) appear to provide a viable alternative to bone-marrow derived stem cells in regenerative medicine. Bone marrow has been used for many years as a treatment of leukemia, and the mesenchymal stem cells (MSCs) contained in transplanted bone marrow have been shown to differentiate into tissue-specific cells in various organs. Although previous results suggested that MSCs derived from bone marrow or skin contain a fraction of pluripotent or multipotent cells, the multipotent cells were not well characterized, because they were considered very rare and lacked a specific surface marker. Kuroda et al. reported a unique subset of human MSCs that can be efficiently isolated as cells double positive for mesenchymal marker CD105+ and human pluripotent stem cell marker stage specific embryonic antigen (SSEA)-3+ cells. They are also able to self-renew and differentiate into cells representative of all three germ layers, namely endodermal, ectodermal, and mesodermal cells from a single cell. These cells were initially identified by applying stress to MSCs and were termed multilineage differentiating stress-enduring cells (Muse cells). Although Muse cells do not have high proliferative activity, they were reported to generate multiple cell types of the three germ layers without inducing unfavorable tumors.

 

Thus, Muse cells appear to be safer than other induced pluripotent or multipotent cells and might have better therapeutic potential than general (non-Muse) MSCs. Although Muse cells were not identified in animals other than a goat, they have been sparsely detected around vessels in various human mesodermal organs or tissues such as the skin and subcutis. Muse cells were also reported to home to injured regions and spontaneously differentiate into tissue specific functional cells in the damaged liver, skin, and skeletal muscle in animal models. In the present report, SSEA-3+ Muse cells were isolated from patient-derived human adipose tissue-derived stem/stromal cells (hASCs). Adipose-derived Muse cells were characterized and evaluated for therapeutic potential in treating diabetic refractory skin ulcers. Skin ulcers under ischemic conditions generally show delayed wound healing and are typical therapeutic targets of cell-based therapies using MSCs or endothelial progenitor cells.

 

In order to investigate whether Muse cells are superior to other MSCs, the study compared wound healing of skin defects in diabetic mice between treatments with the two distinct cell populations.

 

Stage-specific embryonic antigen-3 (SSEA-3)-positive multipotent mesenchymal cells (multilineage differentiating stress-enduring [Muse] cells) were isolated from cultured human adipose tissue derived stem/stromal cells (hASCs) and characterized, and their therapeutic potential for treating diabetic skin ulcers was evaluated. Cultured hASCs were separated using magnetic-activated cell sorting into positive and negative fractions, a SSEA-3+ cell-enriched fraction (Muse-rich) and the remaining fraction (Muse-poor). Muse-rich hASCs showed upregulated and downregulated pluripotency and cell proliferation genes, respectively, compared with Muse-poor hASCs. These cells also released higher amounts of certain growth factors, particularly under hypoxic conditions, compared with Muse-poor cells.

 

Skin ulcers were generated in severe combined immunodeficiency (SCID) mice with type 1 diabetes, which showed delayed wound healing compared with nondiabetic SCID mice. Treatment with Muse-rich cells significantly accelerated wound healing compared with treatment with Muse-poor cells. Transplanted cells were integrated into the regenerated dermis as vascular endothelial cells and other cells. However, they were not detected in the surrounding intact regions. Thus, the selected population of ASCs has greater therapeutic effects to accelerate impaired wound healing associated with type 1 diabetes. These cells can be achieved in large amounts with minimal morbidity and could be a practical tool for a variety of stem cell-depleted or ischemic conditions of various organs and tissues.

 

In the present study, a selected population of ASCs, namely Muse cells, was shown to have greater therapeutic effects in accelerating the impaired wound healing associated with type 1 DM. On the basis of the suspected mechanisms, the data gathered further suggest their clinical potential in a variety of stem cell-depleted or ischemic conditions of any organ or tissue. Adipose tissue has been gaining more attention as a practical source of adult stem cells.

 

The therapeutic potentials of ASCs were suggested for treating various DM conditions, such as hyperglycemia and autoimmune DM. ASCs were shown to share most biological characteristics, and to have comparable functions, with bone marrow-derived MSCs. Recent studies have suggested that ASCs (and also other tissue-resident MSCs) can be supplied from the bone marrow as tissue-localized stem/progenitor cells.

 

Bone marrow is the central factory and bank of stem/ progenitor cells, which are mobilized and delivered on demand by peripheral organs. These data suggest that invasive damage to the bone marrow while harvesting bone marrow-derived cells might have been underestimated. ASCs can be obtained in much larger quantities using minimally invasive approaches that will not damage the bone marrow, suggesting a clinical potential for Muse ASCs in the future.

Access the whole study here.

And Best Performance by an Anti-Aging Vitamin Goes to…

By
Editor
-
0
And Best Performance by an Anti-Aging Vitamin Goes to...

Alberta-based Life Choice made the big time in Hollywood last Sunday when two of its anti-aging products – available at natural health product online marketplace Vitarock.com — were included in gift bags given to every Oscar nominee.

All of Sunday night’s 87th Academy Award nominees were winners, but not because they all left with the coveted statue. It’s because they went home with a swag bag valued at an estimated $125,000, including Life Choice’s anti-aging Homeopathic HgH+ and DMAE Restorative Cream. They’re both available on natural health product online marketplace Vitarock.com — celebrity status optional.

Founded by Dr. Eldon G. Dahl in Cochrane, Alberta, Life Choice has been producing supplements and other natural products since 1986. DMAE Restorative Cream helps reverse signs of aging with amino and alpha lipoic acids. It reduces the appearance of fine lines and wrinkles and enhances skin to look years younger.

Homeopathic HgH+ encourages the body to produce more of the human growth hormone (HgH) to enhance immune response, increase lean body mass, stimulate neuro-endocrine system balance, and achieve optimal physical and mental performance.

Like all of natural health product online store Vitarock’s products, these anti-aging marvels are GMO-free and made with natural ingredients.

About Vitarock
Based in Toronto, Canada, Vitarock is an online marketplace featuring 1000s of ethically produced natural products that don’t harm your health or pollute the environment, are made with ingredients that aren’t tested on animals, and contain as many fair trade ingredients as possible. They all adhere to our company pillars of Pure, Green, Safe and Fair.

PEI Company Launches All Natural Honey Gummies

By
Editor
-
0
PEI Company Launches All Natural Honey Gummies

The Charlottetown Guardian just featured a story of sweet success for a local natural health product manufacturer Island Abbey Foods.

Six years ago, the company introduced the world’s first 100 per cent pure solid honey lozenge – the Honeydrop.

Now their new line of Honibe gummy multivitamins for adults and kids are rolling out province-wide through Murphy’s Pharmacies.

“Staying true to our promise, pure Canadian honey is the number one ingredient in our honey gummy vitamins, thus cutting refined sugar by 50 per cent versus leading brands,’’ says Island Abbey founder and CEO John Rowe.

The company gave away free samples during the launch at Murphy’s Pharmacies Parkdale and gave consumers a chance to enter to win a year’s supply.

Ryan Murphy, Murphy’s Pharmacies VP of operations, commented, “Honibe honey gummies are an attractive option to improve the health of the whole family.’’

Island Abbey Foods promises that “Honibe honey is sourced from 100 per cent Canadian Grade A honey from P.E.I. and Canadian beekeepers.”

 

 

1...277278279...388Page 278 of 388

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© 2026 IHR Magazine | Canada's Natural Health Industry Authority | Le guide de l’industrie canadienne de la santé naturelle